US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by CNS Pharmaceuticals, Inc.

News headline image
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Tickers CNSP
News headline image
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Tickers CNSP
News headline image
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Tickers CNSP